From Laboratory Innovation to Commercial Reality

At Amoli CDMO, we specialize in seamless technology transfer and efficient scale-up — transforming laboratory processes into commercially viable, compliant, and reproducible manufacturing operations.

With over 30 years of pharmaceutical manufacturing experience, Amoli brings together strong scientific foundations, proven project management, and modern process-engineering tools to ensure smooth transition from development to production without compromising quality, timelines, or yield.

Seamless and Structured Tech Transfer

Our technology transfer process is designed to minimize risk and maximize process understanding. It begins with a comprehensive evaluation of the process, analytical methods, and control strategies developed during R&D.

Amoli’s dedicated Tech Transfer Team, comprising scientists, engineers, and quality professionals, ensures that every parameter — from raw material sourcing to analytical release criteria — is clearly defined, verified, and documented before implementation at scale.

Key activities include:

• Detailed review of the process and analytical data packages
• Identification of critical process parameters (CPPs) and quality attributes (CQAs)
• Equipment mapping and compatibility assessment between sites
• Development of a robust technology transfer protocol and acceptance criteria
• Execution of engineering and verification batches under close supervision
• Real-time communication and collaborative decision-making with clients

Our philosophy is simple: predict, plan, and perform — ensuring the transferred process behaves exactly as intended, every time.

Efficient and Reliable Scale-Up

Scaling up a process from laboratory to pilot and commercial scale requires deep scientific insight and engineering precision.

At Amoli, we apply Quality by Design (QbD) principles and Design of Experiments (DoE) tools to understand process behavior and define scalable parameters early in development.

Our scale-up strategy includes:

• Reaction and equipment modeling to define scale-dependent variables
• Material balance and heat transfer evaluation
• Kinetic and thermodynamic data analysis
• Controlled pilot runs to establish process predictability
• Validation of cleaning, drying, and isolation procedures
• Process safety assessments using appropriate containment and hazard studies

Our pilot and demonstration facilities mirror commercial operations, enabling a "right first time” approach to full-scale manufacturing.

Cross-Functional Collaboration

Amoli’s strength lies in the synergy between its Process Development, Analytical, Engineering, and Quality teams.

This cross-functional model ensures that every scale-up and transfer activity is scientifically justified, risk-assessed, and regulatory compliant.

We maintain continuous communication with our partners throughout each stage, providing transparent progress reports, technical reviews, and documented data packages that support regulatory submissions.

Regulatory and Quality Alignment

All technology transfer and scale-up activities are conducted under cGMP and aligned with international regulatory expectations (ICH Q8, Q10, and Q11).

We prepare comprehensive documentation, including:

• Technology Transfer Reports
• Process Validation Master Plans
• Change Control Documentation (MoC)
• Analytical Method Transfer Reports
• Risk Assessment and Mitigation Plans

Our rigorous documentation ensures readiness for regulatory inspections and smooth integration into commercial manufacturing workflows.

Your Molecule. Our Expertise. One Smooth Transition.

With a deep commitment to precision, transparency, and partnership, Amoli CDMO enables clients to move from laboratory-scale breakthroughs to commercial-scale success with confidence.

Whether it’s a new chemical entity, a complex intermediate, or a high-value API, we ensure your process is transferred, scaled, and validated efficiently — reducing time to market and enhancing global reliability.